Pneumonia During the COVID-19 Pandemic in Hubei Province, China: a Case Report of Mucormycosis

Mucor infection cannot be ignored in patients with pulmonary shadowing with cavitation. This paper reports a case of mucormycosis during the COVID-19 pandemic in Hubei Province, China. An anesthesiology doctor was initially diagnosed as COVID-19 due to changes in lung imaging. After anti-infective,...

Full description

Saved in:
Bibliographic Details
Published inClinical laboratory (Heidelberg) Vol. 69; no. 5
Main Authors Wu, Shimin, Song, Jiangqin, Hu, Fuying, Li, Huashun, Tian, Youjun, Cheng, Weijia, Liang, Ying, Luo, Qian
Format Journal Article
LanguageEnglish
Published Germany 01.01.2023
Subjects
Antiviral Agents
Bronchoalveolar Lavage Fluid
China - epidemiology
COVID-19
High-Throughput Nucleotide Sequencing
Humans
Invasive Fungal Infections
Mucormycosis - diagnosis
Mucormycosis - epidemiology
Pandemics
Pneumonia
China
Online AccessGet more information

Cover

More Information
Summary:Mucor infection cannot be ignored in patients with pulmonary shadowing with cavitation. This paper reports a case of mucormycosis during the COVID-19 pandemic in Hubei Province, China. An anesthesiology doctor was initially diagnosed as COVID-19 due to changes in lung imaging. After anti-infective, anti-viral, and symptomatic supportive treatment, some of symptoms were relieved. But some symptoms -'chest pain and discomfort', accompanied by chest sulking and short breath after activities, did not ease. At last, Lichtheimia ramose was detected later by metagenomic next generation sequencing (mNGS) in the bronchoalveolar lavage fluid (BALF). After adjusting amphotericin B for anti-infective treatment, the patient's infection lesions were shrunk and the symptoms were significantly relieved. The diagnosis of invasive fungal infections is very difficult, and mNGS can make an accurate pathogenic diagnosis of invasive fungal diseases for the clinic and provide a basis for clinical treatment.
ISSN:1433-6510
DOI:10.7754/Clin.Lab.2022.220905